Toxicology studies

In preclinical studies, understanding the potential toxicity of a test drug is crucial. Various toxicology studies are conducted at different stages of the drug development process, in order to identify unwanted effects or toxicities.


emka TECHNOLOGIES solutions are specifically designed to help researchers during general toxicology studies, and especially in vivo GLP repeat-dose cardiotoxicity studies.

Our integrated solutions allow for easy acquisition and analysis of ECG and blood pressure from rodents and large laboratory animals.

A smooth transition from paper to digital

In vivo studies offer a guideline for safe dosing and biomarkers to follow in clinical studies and any target organs affected by the compound. Whatever the modality chosen to acquire your parameters of interest, we’ll accompany and guide you at all levels, with an easy-to-use, flexible and fully GLP-compliant solution for your daily experiments.


The studyDESIGNER platform provides organization, data management, workflow guidance and automation for both the technicians and the study directors. The platform was designed to focus on secure noise free collection and automated post-processing to shorten time to reporting.


Save time and get reliable data using one of our available methods, integrated with studyDESIGNER solution. Widely used by many pharmaceutical companies and CRO, our well-proven solutions adapt to your needs:

Save time

Comply with regulatory guidance

Scroll to learn more

By browsing this website, you accept the use of cookies for statistical purposes.

Privacy Settings saved!
Cookie Services

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are set through our site by our advertising partners.

We use Google Tag Manager to monitor our traffic and to help us AB test new features.

We use Adwords to track our Conversions through Google Clicks.

We use Hubspot to monitor our traffic and to help us AB test new features.

Decline all Services
Accept all Services